Stocks · Healthcare · Medical - Devices
Penumbra, Inc. PEN
$317.55 -0.14% Close, Oct 2, 2026 · NYSE · Market cap $12.51B
High qualityLow risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Revenue over the last four quarters was $1.50B, up 17.6% from a year earlier.
- Diluted EPS over the last four quarters was $4.07, up 8.2% year over year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 35%
- EPS growth (TTM, YoY)Bottom 49%
- FCF growth (TTM, YoY)Top 37%
- Revenue growth, 3-year CAGRTop 33%
- Revenue growth accelerationTop 41%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 18%
- Gross marginTop 46%
- Operating marginTop 22%
- Cash conversion (OCF / net income)Top 41%
- Accruals (lower is better)Bottom 47%
- Net debt / EBITDA (lower is better)Top 36%
- Interest coverTop 3%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 26%
- Free-cash-flow yieldTop 31%
- EBITDA / enterprise valueTop 33%
- Sales / enterprise valueBottom 35%
- P/E vs own 5-year history (lower is better)Top 32%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 44%
- 6-month returnBottom 39%
- 1-year return vs S&P 500Top 39%
- Distance from 52-week highTop 19%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 30%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 9%
- Upside to consensus price targetBottom 11%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 1%
- Maximum drawdown, 3 yearsTop 13%
- Beta vs S&P 500 (lower is better)Top 3%
- Net debt / EBITDA (lower is better)Top 36%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 17.3% | 17.6% | ↑ |
| EPS growth (YoY) | 309.4% | 8.2% | ↓ |
| Gross margin | 66.5% | 67.8% | ↑ |
| Operating margin | 12.4% | 12.4% | ↑ |
| FCF margin | 12.6% | 14.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 17.6% | 17.3% | ↑ | Top 35% |
| EPS growth (TTM, YoY) | 8.2% | 309.4% | ↓ | Bottom 49% |
| Gross margin | 67.8% | 66.5% | ↑ | Top 46% |
| Operating margin | 12.4% | 12.4% | ↑ | Top 22% |
| Net margin | 10.7% | 11.5% | ↓ | — |
| Free-cash-flow margin | 14.3% | 12.6% | ↑ | — |
| Return on invested capital | 8.4% | — | Top 18% | |
| Revenue growth, 3-year CAGR | 18.3% | — | Top 33% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.73×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 4.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -9.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.03×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 144.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.16%
- Shareholder yield
- -0.16%
- Share count change, 1 year
- +0.8%
- Share count change, 3-year CAGR
- +0.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- -8.6%
- Average 2-day reaction, last 8
- -0.4%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $320.00
- Target vs current price
- +0.8%
- Analysts with a rating
- 22
- Share rating Buy or Strong Buy
- 41%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | -24.1% | -0.1% | +1.0% | +0.9% | — |
| May 6, 2026 | -21.2% | +0.1% | -0.3% | -1.4% | -0.8% |
| Feb 25, 2026 | +6.3% | -0.3% | +0.2% | -1.6% | -3.6% |
| Nov 5, 2025 | +4.4% | -4.1% | +19.0% | +21.5% | +51.9% |
| Jul 29, 2025 | +6.2% | -1.3% | +4.4% | +14.8% | +8.2% |
| Apr 23, 2025 | +25.8% | +0.6% | +7.1% | +1.4% | -16.9% |
| Feb 18, 2025 | +10.2% | +0.9% | +7.1% | +2.8% | +10.2% |
| Oct 30, 2024 | +23.2% | +0.8% | +10.9% | +18.8% | +29.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | $0.88 | $1.16 | -24.1% | $390.0M |
| May 6, 2026 | $0.82 | $1.04 | -21.2% | $374.8M |
| Feb 25, 2026 | $1.18 | $1.11 | +6.3% | $385.4M |
| Nov 5, 2025 | $0.97 | $0.93 | +4.4% | $354.7M |
| Jul 29, 2025 | $0.86 | $0.81 | +6.2% | $339.5M |
| Apr 23, 2025 | $0.83 | $0.66 | +25.8% | $324.1M |
| Feb 18, 2025 | $0.97 | $0.88 | +10.2% | $315.5M |
| Oct 30, 2024 | $0.85 | $0.69 | +23.2% | $301.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 78.0× | 245.7× | 24th | Top 26% |
| P/E (forward) | 67.4× | — | — | — |
| EV / EBITDA | 56.3× | — | — | Top 33% |
| EV / Sales | 8.32× | — | — | Bottom 35% |
| Free-cash-flow yield | 1.73% | — | — | Top 31% |
| Earnings yield | 1.28% | — | — | Top 26% |
P/E over the past five years
Range 54.0× – 403.3× since Sep 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +27.2%
- Earnings per share growth (TTM)
- +8.2%
- Change in P/E multiple
- +30.1%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +0.2%
- 200-day average slope (20 days)
- +0.8%
- Distance from 50-day average
- -1.3%
- Distance from 200-day average
- -2.8%
- RSI (14)
- 39.3
- Relative volume
- 0.62×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 6.3%
- Volatility vs own 5-year history
- 1th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.00
- Correlation with S&P 500
- 0.00
- Current drawdown from 1-year high
- -11.6%
- Maximum drawdown, 3 years
- -40.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 28, 2021 | Jun 16, 2022 | -62.6% | 287 days | 224 days (May 9, 2023) |
| Jun 30, 2023 | Aug 7, 2024 | -52.4% | 277 days | 361 days (Jan 15, 2026) |
| Nov 12, 2020 | Dec 16, 2020 | -35.9% | 23 days | 36 days (Feb 9, 2021) |
| Mar 1, 2021 | Mar 29, 2021 | -12.8% | 20 days | 18 days (Apr 23, 2021) |
| Jan 27, 2026 | Jun 29, 2026 | -12.2% | 105 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $12.51B
- P/E (TTM)
- 78.0
- EPS, diluted (TTM)
- $4.07
- Revenue (TTM)
- $1.50B
- 52-week range
- $221.26 – $362.41
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $747.6M | $847.1M | $1.06B | $1.19B | $1.40B |
| Gross profit | $475.4M | $535.2M | $682.6M | $755.0M | $942.4M |
| Operating income | -$7.5M | $6.1M | $73.6M | $86.2M | $189.2M |
| Net income | $5.3M | -$2.0M | $91.0M | $14.0M | $177.7M |
| EPS (diluted) | $0.14 | -$0.05 | $2.32 | $0.36 | $4.52 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $301.0M | $315.5M | $324.1M | $339.5M | $354.7M | $385.4M | $374.8M | $390.0M |
| Net income | $29.5M | $33.7M | $39.2M | $45.3M | $45.9M | $47.3M | $32.6M | $34.8M |
| EPS (diluted) | $0.75 | $0.86 | $1.00 | $1.15 | $1.17 | $1.20 | $0.82 | $0.88 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $9.5M | -$55.7M | $97.3M | $168.5M | $238.7M |
| Capital expenditure | -$21.2M | -$19.3M | -$15.2M | -$21.2M | -$63.7M |
| Free cash flow | -$11.7M | -$75.0M | $82.1M | $147.3M | $174.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $18.4M | $21.6M | $20.4M | -$83.2M | $31.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $658.8M
- Total assets
- $1.97B
- Total liabilities
- $444.0M
- Total debt
- $212.7M
- Net debt
- $7.4M
- Shareholders’ equity
- $1.53B
As of Jun 30, 2026 (filed Jul 30, 2026).
Short interest
- Shares sold short
- 1,805,942
- Days to cover
- 7.18
- Change vs previous report
- +4.3%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 16, 2014
- 1-for-10